ym 529 has been researched along with bazedoxifene in 1 studies
| Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) |
|---|---|---|---|---|---|
| 140 | 23 | 71 | 307 | 69 | 249 |
| Protein | Taxonomy | ym 529 (IC50) | bazedoxifene (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0091 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.44 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0444 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, I; Matsumoto, T | 1 |
1 other study(ies) available for ym 529 and bazedoxifene
| Article | Year |
|---|---|
[New approved drugs for osteoporosis in Japan].
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Indoles; Japan; Osteoporosis; Parathyroid Hormone; Teriparatide; Vitamin D | 2012 |